数据统计显示，中证医疗指数近一个月上涨4.50%，近三个月下跌4.01%，年至今上涨1.46%。 从中证医疗指数持仓样本的行业来看，医药卫生占比97.55%、信息技术占比2.18%、主要消费占比 0.27%。 资料显示，指数样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一个定期 调整日前，权重因子一般固定不变。特殊情况下将对指数进行临时调整。当样本退市时，将其从指数样 本中剔除。样本公司发生收购、合并、分拆等情形的处理，参照计算与维护细则处理。 金融界6月6日消息，A股三大指数收盘涨跌不一，中证医疗指数 (中证医疗，399989)下跌0.94%，报 6591.32点，成交额113.31亿元。 据了解，中证医疗指数选取业务涉及医疗器械、医疗服务、医疗信息化等医疗主题的医药卫生行业上市 公司证券作为指数样本，以反映医疗主题上市公司证券的整体表现。该指数以2004年12月31日为基日， 以1000.0点为基点。 从指数持仓来看，中证医疗指数十大权重分别为：药明康德（11.63%）、迈瑞医疗（9.59% ...

金融界6月6日消息，A股三大指数收盘涨跌不一，中证苏银理财长三角创新指数 (苏银理财长三角， 931559)下跌0.05%，报1822.5点，成交额312.53亿元。 从指数持仓来看，中证苏银理财长三角创新指数十大权重分别为：澜起科技（6.44%）、海康威视 （4.83%）、国电南瑞（4.75%）、中微公司（4.45%）、联影医疗（4.23%）、沪电股份（3.63%）、思 源电气（3.47%）、恒生电子（3.12%）、新和成（2.58%）、天孚通信（2.3%）。 从中证苏银理财长三角创新指数持仓的市场板块来看，上海证券交易所占比56.30%、深圳证券交易所 占比43.70%。 从中证苏银理财长三角创新指数持仓样本的行业来看，信息技术占比43.30%、工业占比28.45%、医药 卫生占比16.07%、通信服务占比6.62%、可选消费占比4.08%、原材料占比1.48%。 资料显示，中证苏银理财长三角创新指数的样本每半年调整一次，样本调整实施时间分别为每年6月和 12月的第二个星期五的下一交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实 施时间相同。在下一个定期调整日前，权重因子一般固定不变。特 ...

Core Viewpoint - The China Securities Index for Hong Kong Stock Connect Medical Theme Index has shown a recent decline of 0.75%, but it has experienced significant growth over the past months, with a year-to-date increase of 28.05% [1] Group 1: Index Performance - The China Securities Index for Hong Kong Stock Connect Medical Theme Index closed at 849.54 points with a trading volume of 15.301 billion yuan [1] - Over the past month, the index has increased by 6.08%, and over the last three months, it has risen by 9.80% [1] Group 2: Index Composition - The index comprises 50 listed companies involved in medical devices, medical services, pharmaceuticals, and biotechnology [1] - The top ten weighted companies in the index include WuXi Biologics (16.26%), JD Health (10.67%), Alibaba Health (6.31%), WuXi AppTec (5.79%), China National Pharmaceutical Group (5.31%), Kingstar BioTech (4.27%), Weigao Group (3.31%), Innovent Biologics (3.06%), CSPC Pharmaceutical Group (2.51%), and MicroPort Scientific Corporation (2.4%) [1] Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]

从中证香港美国上市中美科技指数持仓的市场板块来看，纳斯达克全球精选市场证券交易所 (Consolidated Issue)占比41.82%、香港证券交易所占比35.21%、纽约证券交易所占比21.28%、纳斯达克 证券交易所(Consolidated Capital Market)占比1.69%。 从中证香港美国上市中美科技指数持仓样本的行业来看，信息技术占比39.19%、可选消费占比 20.43%、医药卫生占比15.96%、通信服务占比14.29%。 资料显示，指数样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一个定期 调整日前，权重因子一般固定不变。特殊情况下将对指数进行临时调整。如果新上市中国和美国科技公 司市值分别在中国样本公司和美国样本公司中排名前五，将在其上市第十一个交易日快速纳入指数。当 样本退市时，将其从指数样本中剔除。样本公司发生收购、合并、分拆等情形的处理，参照计算与维护 细则处理。 数据统计显示，中证香港美国上市中美科技指数近一个月上涨4.77%，近三个月上涨2.89%，年 ...

Core Viewpoint - The Zhongzheng Guangyin Wealth Management Hong Kong-Shenzhen Technology Leaders Index has shown a mixed performance, with a recent increase but a decline over the past three months, indicating volatility in the technology sector [1][2] Group 1: Index Performance - The Zhongzheng Guangyin Wealth Management Hong Kong-Shenzhen Technology Leaders Index rose by 1.15% to 2180.95 points, with a trading volume of 91.926 billion yuan [1] - Over the past month, the index has increased by 1.53%, while it has decreased by 6.24% over the last three months, and it has risen by 9.71% year-to-date [1] Group 2: Index Composition - The index comprises 50 large-cap listed companies from the information technology, biomedicine, and high-end manufacturing sectors, reflecting the overall performance of technology leaders in the mainland and Hong Kong markets [1] - The top ten holdings in the index include Alibaba-W (11.98%), Tencent Holdings (10.74%), Xiaomi Group-W (10.53%), CATL (8.42%), BYD Company (5.81%), and others [1] - The market distribution of the index holdings shows that the Hong Kong Stock Exchange accounts for 49.63%, the Shenzhen Stock Exchange for 28.12%, and the Shanghai Stock Exchange for 22.25% [1] Group 3: Industry Breakdown - The industry composition of the index holdings includes 31.19% in information technology, 23.16% in consumer discretionary, 18.11% in industrials, 15.02% in communication services, and 12.53% in healthcare [2] - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [2]

金融界5月27日消息，上证指数低开震荡，中证高端制造50指数 (高端造50，932025)报1354.87点。 数据统计显示，中证高端制造50指数近一个月上涨2.03%，近三个月下跌9.35%，年至今下跌3.60%。 据了解，中证高端制造50指数，选取信息技术、通信设备、电力设备、航空航天与国防、机械制造、医 药卫生、环保、汽车及零配件、油气开采等行业的50只有代表性的上市公司证券作为指数样本，以反映 高端制造领域上市公司证券的整体表现。该指数以2016年12月30日为基日，以1000.0点为基点。 从指数持仓来看，中证高端制造50指数十大权重分别为：宁德时代（13.67%）、比亚迪（6.87%）、恒 瑞医药（4.86%）、中芯国际（3.36%）、药明康德（3.17%）、立讯精密（3.15%）、汇川技术 （2.89%）、京东方A（2.88%）、迈瑞医疗（2.81%）、北方华创（2.79%）。 从中证高端制造50指数持仓的市场板块来看，深圳证券交易所占比54.16%、上海证券交易所占比 45.84%。 从中证高端制造50指数持仓样本的行业来看，工业占比38.50%、信息技术占比29.34%、可选消费占比 15. ...

数据统计显示，中证上海科技领先指数近一个月上涨3.22%，近三个月下跌6.91%，年至今上涨5.45%。 资料显示，指数样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。若原样本在所属中证二级行业内总市值排名位于前2名则优先保留。每次调整的样本比例一般 不超过30%。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一个 定期调整日前，权重因子一般固定不变。特殊情况下将对指数进行临时调整。当样本退市时，将其从指 数样本中剔除。样本公司发生收购、合并、分拆等情形的处理，参照计算与维护细则处理。 据了解，中证上海科技领先指数选取上海市50只盈利能力强、成长能力强、研发投入高的上市公司证券 作为指数样本，以反映上海地区科技领域上市公司证券的整体表现。该指数以2018年12月28日为基日， 以1000.0点为基点。 从中证上海科技领先指数持仓的市场板块来看，上海证券交易所占比77.27%、深圳证券交易所占比 22.73%。 金融界5月21日消息，上证指数上涨0.21%，中证上海科技领先指数 (上海科技领先，932157)报1547.52 点。 从中证上海科 ...

Core Points - The Shanghai Composite Index rose by 0.21%, while the Shanghai China Manufacturing Theme Index increased by 0.1%, closing at 1417.05 points with a trading volume of 40.378 billion yuan [1] - Over the past month, the Shanghai China Manufacturing Theme Index has increased by 2.74%, but it has decreased by 6.30% over the last three months and is down 3.76% year-to-date [1] - The index includes representative listed companies in sectors such as new generation information technology, high-end CNC machine tools and robotics, aerospace equipment, energy-saving and new energy vehicles, electric power equipment, new materials, biomedicine, and high-performance medical devices [1] Index Composition - The top ten weighted stocks in the Shanghai China Manufacturing Theme Index are: Wanhua Chemical (4.13%), Guodian NARI (3.56%), Longi Green Energy (3.54%), CRRC (3.43%), China Shipbuilding (2.72%), Kingsoft Office (2.55%), Tebian Electric (2.32%), United Imaging (2.2%), AVIC Shenyang Aircraft (2.03%), and China Shipbuilding Industry Corporation (1.95%) [1] - The index is fully composed of stocks listed on the Shanghai Stock Exchange, with a 100% representation [1] Industry Breakdown - The industry composition of the index shows that industrials account for 55.63%, information technology for 16.96%, materials for 14.03%, healthcare for 11.77%, and consumer discretionary for 1.62% [2] - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]

Market Performance - The CSI Hong Kong Stock Connect Healthcare Index (930965) increased by 1.66% as of April 29, 2025, with notable gains from WuXi AppTec (02359) up 5.07%, and 3SBio (01530) up 4.41% [1] - The Hong Kong Healthcare ETF (159718) rose by 1.84%, closing at 0.72 yuan, with a weekly increase of 4.28% as of April 28, 2025 [1] - The CSI Pharmaceutical and Medical Device Innovation Index (931484) saw a rise of 0.51%, with significant increases from companies like Xingqi Eye Hospital (300573) up 9.55% and WuXi AppTec (603259) up 3.80% [4][10] Liquidity and Scale - The Hong Kong Healthcare ETF had a turnover rate of 4.77% with a transaction volume of 12.78 million yuan, averaging daily transactions of 152 million yuan over the past week [1] - The Medical Innovation ETF had a turnover rate of 0.23% with a transaction volume of 3.81 million yuan, averaging daily transactions of 52.36 million yuan over the past month [5] Investment Trends - The upcoming ASCO conference from May 30 to June 3, 2025, is expected to showcase over 70 oral presentations and 10 significant studies from domestic innovative drug companies [2] - According to Guotou Securities, global and U.S. VC & PE investment in innovative drugs is projected to grow by 1.93% and 5.29% respectively in 2024, indicating a recovery in the investment environment for innovative drugs [2] - Demand for research and development in areas such as peptides and ADCs is increasing, leading to improved order conditions for CXO listed companies like WuXi AppTec and others [2] Index Composition - The top ten weighted stocks in the CSI Hong Kong Stock Connect Healthcare Index account for 59.76%, with WuXi Biologics (02269) holding the highest weight at 11.32% [7][9] - The top ten weighted stocks in the CSI Pharmaceutical and Medical Device Innovation Index represent 66.49%, with WuXi AppTec (603259) at 11.68% [10][12]